Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice
about
Mechanism of New Bone Formation in Axial Spondyloarthritis.Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.Bone Disease in Axial Spondyloarthritis.Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis.What is the best treatment target in axial spondyloarthritis: tumour necrosis factor α, interleukin 17, or both?Cytokines and integrins related to inflammation of joint and gut in patients with spondyloarthritis and inflammatory bowel disease.
P2860
Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Update on interleukin-17: a ro ...... lication for clinical practice
@en
Update on interleukin-17: a ro ...... ication for clinical practice.
@nl
type
label
Update on interleukin-17: a ro ...... lication for clinical practice
@en
Update on interleukin-17: a ro ...... ication for clinical practice.
@nl
prefLabel
Update on interleukin-17: a ro ...... lication for clinical practice
@en
Update on interleukin-17: a ro ...... ication for clinical practice.
@nl
P2860
P1433
P1476
Update on interleukin-17: a ro ...... lication for clinical practice
@en
P2093
Pierre Miossec
P2860
P304
P356
10.1136/RMDOPEN-2016-000284
P577
2017-02-15T00:00:00Z